These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6750314)

  • 21. The stimulating effect of 3',5'-(cyclic)adenosine monophosphate and lipolytic hormones on 3-O-methylglucose transport and 45Ca2+ release in adipocytes and skeletal muscle of the rat.
    Rasmussen MJ; Clausen T
    Biochim Biophys Acta; 1982 Dec; 693(2):389-97. PubMed ID: 6297557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose transport and metabolism in adipocytes from newly diagnosed untreated insulin-dependent diabetics. Severely impaired basal and postinsulin binding activities.
    Hjøllund E; Pedersen O; Richelsen B; Beck-Nielsen H; Sørensen NS
    J Clin Invest; 1985 Dec; 76(6):2091-6. PubMed ID: 4077975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin binding and hexose transport in rat adipocytes. Relation to cell size.
    Foley JE; Laursen AL; Sonne O; Gliemann J
    Diabetologia; 1980 Sep; 19(3):234-41. PubMed ID: 6997125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of fasting on insulin binding, glucose transport, and glucose oxidation in isolated rat adipocytes: relationships between insulin receptors and insulin action.
    Olefsky JM
    J Clin Invest; 1976 Dec; 58(6):1450-60. PubMed ID: 993354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of fasting on insulin receptor binding and insulin action in different human subcutaneous fat depots.
    Engfeldt P; Bolinder J; Ostman J; Arner P
    J Clin Endocrinol Metab; 1985 May; 60(5):868-73. PubMed ID: 3884649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistant glucose transport activity in adipose cells from the SHR/N-corpulent rat.
    Baly DL; Zarnowski MJ; Carswell N; Michaelis OE
    J Nutr; 1989 Apr; 119(4):628-32. PubMed ID: 2649647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phorbol esters imitate in rat fat-cells the full effect of insulin on glucose-carrier translocation, but not on 3-O-methylglucose-transport activity.
    Mühlbacher C; Karnieli E; Schaff P; Obermaier B; Mushack J; Rattenhuber E; Häring HU
    Biochem J; 1988 Feb; 249(3):865-70. PubMed ID: 3281656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between negative cooperativity and insulin action.
    Olefsky JM; Green A; Ciaraldi TP; Saekow M; Rubenstein AH; Tager HS
    Biochemistry; 1981 Jul; 20(15):4488-92. PubMed ID: 7025901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of fasting and refeeding on the antilipolytic effect of insulin in human fat cells obtained from obese subjects.
    Engfeldt P; Bolinder J; Ostman J; Arner P
    Diabetes; 1985 Nov; 34(11):1191-7. PubMed ID: 3899815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport.
    Ciaraldi TP; Molina JM; Olefsky JM
    J Clin Endocrinol Metab; 1991 Apr; 72(4):876-82. PubMed ID: 2005215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
    Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
    J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor binding and effects of insulin and NSILA-S on glucose transport and metabolism in adipocytes from hypophysectomized rats.
    Schoenle E; Zapf J; Froesch ER
    Diabetologia; 1979 Jan; 16(1):41-6. PubMed ID: 761737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes.
    Hansen BC; Jen KL; Schwartz J
    Int J Obes; 1988; 12(5):433-43. PubMed ID: 3069766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation.
    Ong KC; Khoo HE
    Biochem Pharmacol; 1996 Feb; 51(4):423-9. PubMed ID: 8619886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic AMP modulates insulin binding and induces post-receptor insulin resistance of glucose transport in isolated rat adipocytes.
    Kirsch D; Kemmler W; Häring HU
    Biochem Biophys Res Commun; 1983 Aug; 115(1):398-405. PubMed ID: 6193793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of prostaglandin E2, indomethacin and adenosine deaminase on basal and insulin-stimulated glucose metabolism in human adipocytes.
    Richelsen B; Hjøllund E; Pedersen O; Sørensen NS
    Biochim Biophys Acta; 1985 Mar; 844(3):359-66. PubMed ID: 3918586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between insulin binding, insulin activation of insulin-receptor tyrosine kinase, and insulin stimulation of glucose uptake in isolated rat adipocytes. Effects of isoprenaline.
    Klein HH; Matthaei S; Drenkhan M; Ries W; Scriba PC
    Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):787-92. PubMed ID: 2012605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Adrenergic regulation of insulin and epidermal growth factor receptors in rat adipocytes.
    Pessin JE; Gitomer W; Oka Y; Oppenheimer CL; Czech MP
    J Biol Chem; 1983 Jun; 258(12):7386-94. PubMed ID: 6134722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipocyte insulin binding and action in moderately obese NIDDM patients after dietary control of plasma glucose: reversal of postbinding abnormalities.
    Hjøllund E; Pedersen O; Sørensen NS
    Diabetes Care; 1987; 10(3):306-12. PubMed ID: 3595396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.